Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
(CSE:
MDMA
)
0.1150
+0.0050 (+4.55%)
Streaming Delayed Price
Updated: 2:41 PM EDT, Oct 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
109,491
Open
0.1100
Bid (Size)
0.1100 (248,500)
Ask (Size)
0.1150 (2,500)
Prev. Close
0.1100
Today's Range
0.1050 - 0.1200
52wk Range
0.0850 - 0.3400
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Small Cap Growth Virtual Investor Conference Agenda Announced for October 16th
October 17, 2025
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
PharmAla Completes Shipment of LaNeo™ MDMA to Johns Hopkins
October 02, 2025
From
PharmAla Biotech
Via
GlobeNewswire
Performance
YTD
-57.4%
-57.4%
1 Month
-4.2%
-4.2%
3 Month
+15.0%
+15.0%
6 Month
-23.3%
-23.3%
1 Year
-34.3%
-34.3%
More News
Read More
Small Cap Growth Virtual Investor Conference Agenda Announced for October 16th
October 14, 2025
From
Virtual Investor Conferences
Via
GlobeNewswire
PharmAla Completes Shipment of LaNeo™ MDMA to Yale University, Provides Investor Update
June 03, 2025
From
PharmAla Biotech
Via
GlobeNewswire
PharmAla Contracts with Partner to Act as US Distributor
March 24, 2025
From
PharmAla Biotech
Via
GlobeNewswire
PharmAla to supply STRONG STAR at UT Health San Antonio, with novel dosage form of LaNeo™ MDMA
February 27, 2025
From
PharmAla Biotech
Via
GlobeNewswire
PharmAla Signs Advisory Agreement with Mr. Matthew Azrieli
February 06, 2025
From
PharmAla Biotech
Via
GlobeNewswire
PharmAla To Supply Merhavim Mental Health Centre Clinical Trial in Exchange for Full Data License, in Partnership with MAPS Israel
January 20, 2025
From
PharmAla Biotech
Via
GlobeNewswire
PharmAla to supply Mt. Sinai Hospital with LaNeo MDMA
October 21, 2024
From
PharmAla Biotech
Via
GlobeNewswire
PharmAla Launches MDMA Clinical Trial Tool for Researchers
August 22, 2024
From
PharmAla Biotech
Via
GlobeNewswire
PharmAla Comments on USFDA Decision regarding MDMA-Assisted Therapy and Announces Patent Granting for ALA-002
August 09, 2024
From
PharmAla Biotech
Via
GlobeNewswire
Canadian Biotech Duo Hits Psilocybin Extraction Milestone For API Development At Scale
May 29, 2024
Via
Benzinga
Cortexa Commences Manufacturing GMP LaNeo™ MDMA in Australia
April 05, 2024
From
PharmAla Biotech
Via
GlobeNewswire
Patent Allowance Granted for ALA-002 Composition by US Patent and Trademark Office
March 27, 2024
From
PharmAla Biotech
Via
GlobeNewswire
Patent Allowance Granted for P-1 Molecule by US Patent and Trademark Office
March 20, 2024
From
PharmAla Biotech
Via
GlobeNewswire
Cortexa Leads the World in First Supply of Psilocybin Under the TGA’s Authorized Prescriber Scheme
March 18, 2024
From
PharmAla Biotech
Via
GlobeNewswire
PharmAla receives new “MDXXF” ticker from FINRA for OTCQB Listing
January 24, 2024
From
PharmAla Biotech
Via
GlobeNewswire
PharmAla-1 Molecule Receives US Patent Prosecution Highway Acceptance
January 08, 2024
From
PharmAla Biotech
Via
GlobeNewswire
PharmAla Begins Trading on OTCQB
September 06, 2023
From
PharmAla Biotech
Via
GlobeNewswire
PharmAla Files Patent for Novel MDXX Molecule PharmAla-1
July 31, 2023
From
PharmAla Biotech
Via
GlobeNewswire
Life Science Investor Forum: Presentations Now Available for Online Viewing
June 23, 2023
From
Virtual Investor Conferences
Via
GlobeNewswire
Life Science Investor Forum Agenda Announced for June 22nd
June 20, 2023
From
Virtual Investor Conferences
Via
GlobeNewswire
USFDA Approves LaNeo MDMA for Clinical Trial Use in the United States
June 09, 2023
From
PharmAla Biotech
Via
GlobeNewswire
PharmAla Biotech to form Australian Psychedelics Joint Venture with Vitura Health
May 01, 2023
From
PharmAla Biotech
Via
GlobeNewswire
Revive Therapeutics Secures MDMA Supply from PharmAla Biotech for MDMA Transdermal Patch Development
February 06, 2023
From
Revive Therapeutics Ltd.
Via
GlobeNewswire
Frequently Asked Questions
Is MDMA publicly traded?
Yes, MDMA is publicly traded.
What exchange does MDMA trade on?
MDMA trades on the Canadian Securities Exchange
What is the ticker symbol for MDMA?
The ticker symbol for MDMA is MDMA on the Canadian Securities Exchange
What is the current price of MDMA?
The current price of MDMA is 0.1150
When was MDMA last traded?
The last trade of MDMA was at 10/31/25 02:41 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today